Distributed Bio Revenue and Competitors
Estimated Revenue & Valuation
- Distributed Bio's estimated annual revenue is currently $4.2M per year.
- Distributed Bio's estimated revenue per employee is $155,000
Employee Data
- Distributed Bio has 27 Employees.
- Distributed Bio grew their employee count by -31% last year.
Distributed Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Project Manager | Reveal Email/Phone |
2 | Senior Scientist | Reveal Email/Phone |
Distributed Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Distributed Bio?
Distributed Bio is engineering a transformative pipeline of universal vaccines and monoclonal antibody therapeutics in major areas of unmet need. Our proprietary Centivax technology enables vaccines against rapidly mutating pathogens such as influenza, HIV, and the flaviviruses. We have leveraged the unique ability of our SuperHuman2.0 antibody discovery technology to generate thousands of best-in-class molecules against 26 critical immune oncology and neurodegeneration targets, enabling our partners to save years of research time. By combining our Tumbler technology and Machine Learning, we bioengineer an internal portfolio of antibodies to address uniquely challenging therapeutic opportunities
keywords:N/AN/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
-31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Distributed Bio News
Albany NY, United States: Healthcare retailers today are growing efforts toward ensuring the proper distribution of medicinal products.
Mining of these repertoires to create highly comprehensive antibody libraries, such as Distributed Bio's SuperHuman 2.0, when combined with large-scale...
Aragen Bioscience (a GVK BIO company) ... Global Antibody Discovery Services Market: Distribution by Steps Involved in Antibody Discovery...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.7M | 28 | 56% | N/A |
#2 | $6.5M | 28 | -15% | N/A |
#3 | $6.5M | 28 | -15% | N/A |
#4 | $3.1M | 29 | 81% | $42M |
#5 | $6M | 30 | -32% | N/A |